Nebenwirkungen · Azacitidine betapharm
Azacitidine betapharm 25 mg/mL powder for suspension for injection · Abschnitt 4.8 · PDF-Seite 7
HOS-292676 · Präparat HOS-287726
System organ Very common Common Uncommon Rare Not known class Infections and pneumonia* sepsis* (including necrotising infestations (including bacterial, bacterial, viral and fasciitis * viral and fungal), fungal), neutropenic nasopharyngitis sepsis*, respiratory tract infection (includes upper and bronchitis), urinary tract infection, cellulitis, diverticulitis, oral fungal infection, sinusitis, pharyngitis, rhinitis, herpes simplex, skin infection Neoplasms Differ- benign, malignant entiation- and unspecified syndrome*,a (including cysts and polyps) Blood and febrile pancytopenia*, bone lymphatic system neutropenia*, marrow failure disorders neutropenia, leukopenia, thrombocytopenia, anaemia Immune system hypersensitivity disorders reactions
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-01-10T14:48:00Z · SHA-256 d53d02b916188fb62a6c5c1423452b9265a2986b8439ff9140970073eef77b2c · Passage 6a6c017bcd716d99d25824603fa9a3a4c87ea23f20150d547ecd5f59da0b5d9c · Zeichen 3014–4802 im Abschnitt